Related Experiment Video
Updated: Jun 14, 2026

Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Biotechnology: delivering on the promise
1Biotechnology Industry Organization, 1201 Maryland Avenue, SW, Washington, DC 20024, USA. jgreenwood@bio.org
Abstract:
The research and development of innovative new therapies are expensive and risky processes, and companies require substantial resources if they are to translate basic science into modern biomedical products. When resources are limited, as in the current economic climate, biotechnology start-up companies are often among the first casualties in the fight for assets. Policy-makers can play an important role in bolstering these important innovators.
Related Concept Videos
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Plant Breeding and Biotechnology
Microorganisms in Medicine and Therapeutics
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Recombinant DNA
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

